LAUSANNE, Switzerland, October 4, 2013 /PRNewswire/ --
Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology and companion diagnostics, will be......
More...
